sorafenib has been researched along with 2-acetylfuranonaphthoquinone in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (2-acetylfuranonaphthoquinone) | Trials (2-acetylfuranonaphthoquinone) | Recent Studies (post-2010) (2-acetylfuranonaphthoquinone) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 79 | 11 | 65 |
| Protein | Taxonomy | sorafenib (IC50) | 2-acetylfuranonaphthoquinone (IC50) |
|---|---|---|---|
| Retinal dehydrogenase 1 | Homo sapiens (human) | 0.4253 | |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 2.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, Y; Iino, S; Kageyama, R; Morimoto, M; Nakamura, S; Okusaka, T | 1 |
1 trial(s) available for sorafenib and 2-acetylfuranonaphthoquinone
| Article | Year |
|---|---|
A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular Carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzofurans; Carcinoma, Hepatocellular; East Asian People; Humans; Liver Neoplasms; Naphthoquinones; Sorafenib | 2023 |